Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Gene editing for sickle cell disease and transfusion dependent thalassemias- A cure within reach

31 Dec 2022

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hemoglobinopathies and Related Disorders
Share to Parvovirus B19 Infection Studies
Share to Prenatal Screening and Diagnostics

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 37080708
DOI: 10.1053/j.seminhematol.2022.12.001

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Gene editing for sickle cell disease and transfusion dependent thalassemias- A cure within reachPMID 37080708Read ↗

Advances in genome editing: the technology of choice for precise and efficient β-thalassemia treatmentSemantic proximity Read ↗

Gene Therapy and Gene Editing for β-ThalassemiaSemantic proximity Read ↗

Welcoming the Era of Gene Editing in MedicineSemantic proximity Read ↗

Therapeutic promise of CRISPR-Cas9 gene editing in sickle cell disease and β-thalassemia: A current reviewSemantic proximity Read ↗

CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-ThalassemiaSemantic proximity Read ↗

The potential of gene therapy approaches for the treatment of hemoglobinopathies: achievements and challengesSemantic proximity Read ↗

Gene Therapy for HemoglobinopathiesSemantic proximity Read ↗

Editing outside the body: Ex vivo gene-modification for β-hemoglobinopathy cellular therapy.Semantic proximity Read ↗

Gene therapy for sickle cell disease: An updateSemantic proximity Read ↗

Genome editing strategies for targeted correction of β-globin mutation in sickle cell disease: From bench to bedside.Semantic proximity Read ↗

Recent advancements in gene therapy for sickle cell disease and β-thalassemiaSemantic proximity Read ↗

Gene therapies for transfusion dependent β‐thalassemia: Current status and critical criteria for successSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.